9/6/2022 8:24:46 AM
Enlivex Gets Notice Of Allowance For U.S. Patent Application For Allocetra To Prevent Cytokine Release Syndrome
9/22/2021 6:04:16 AM
Enlivex Doses First Patient Allocetra Phase IIb Trial In COVID-19 Patients With Acute Respiratory Distress Syndrome
2/9/2021 11:32:42 PM
Enlivex Increases Bought Deal Offering To About $46.0 Mln Of Ordinary Shares